{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:44:30Z","timestamp":1775277870494,"version":"3.50.1"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1097\/mop.0b013e328236743f","type":"journal-article","created":{"date-parts":[[2007,7,13]],"date-time":"2007-07-13T08:32:06Z","timestamp":1184315526000},"page":"389-397","source":"Crossref","is-referenced-by-count":27,"title":["Polycystic ovary syndrome update in adolescence"],"prefix":"10.1097","volume":"19","author":[{"given":"Areej","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210206","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-3-20210206","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/jc.2006-2012","article-title":"Identifying children at risk for polycystic ovary syndrome","volume":"92","author":"Rosenfield","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-3-20210206","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"R4-3-20210206","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zadawski","year":"1992"},{"key":"R5-3-20210206","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R6-3-20210206","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-3-20210206","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3928\/0090-4481-20050901-13","article-title":"Diagnosis and treatment of polycystic ovarian syndrome and insulin resistance","volume":"34","author":"Fleischman","year":"2005","journal-title":"Pediatr Ann"},{"key":"R8-3-20210206","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/GRF.0b013e31802f50fc","article-title":"Polycystic ovary syndrome: early detection in the adolescent.","volume":"50","author":"Jeffrey Chang","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"R9-3-20210206","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09513590410001729194","article-title":"Revisit of metformin treatment in polycystic ovarian syndrome","volume":"19","author":"Lam","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"R10-3-20210206","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.sempedsurg.2005.01.007","article-title":"Polycystic ovary syndrome in adolescent girls","volume":"14","author":"Pfeifer","year":"2005","journal-title":"Semin Pediatr Surg"},{"key":"R11-3-20210206","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2165\/00003495-200666070-00002","article-title":"Diagnosis and management of polycystic ovary syndrome: a practical guide","volume":"66","author":"Stankiewicz","year":"2006","journal-title":"Drugs"},{"key":"R12-3-20210206","first-page":"1343","article-title":"The overweight adolescent: prevention, treatment, and obstetric-gynecologic implications","volume":"108","author":"Opinion","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R13-3-20210206","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.beem.2006.03.008","article-title":"Role of lifestyle modification in the management of polycystic ovary syndrome","volume":"20","author":"Hoeger","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R14-3-20210206","first-page":"73","article-title":"Polycystic ovary syndrome in adolescents","volume":"13","author":"Kent","year":"2002","journal-title":"Adolesc Med"},{"key":"R15-3-20210206","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2006.04.028","article-title":"Puberty and polycystic ovary syndrome.","volume":"254-","author":"Witchel","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"R16-3-20210206","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0015-0282(02)03275-2","article-title":"Molecular progress in infertility: polycystic ovary syndrome","volume":"78","author":"Legro","year":"2002","journal-title":"Fertil Steril"},{"key":"R17-3-20210206","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.beem.2006.02.005","article-title":"Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome","volume":"20","author":"Goodarzi","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R18-3-20210206","first-page":"321","article-title":"Polycystic ovary syndrome","volume":"10","author":"Kahn","year":"1999","journal-title":"Adolesc Med"},{"key":"R19-3-20210206","article-title":"Androgen abnormalities in the adolescent girl","author":"Emans","year":"2005"},{"key":"R20-3-20210206","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jc.2005-1994","article-title":"Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial","volume":"91","author":"Eisenhardt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-3-20210206","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000084099","article-title":"Polycystic ovary syndrome in adolescence: new insights in pathophysiology and treatment","volume":"8","author":"Homburg","year":"2005","journal-title":"Endocr Dev"},{"key":"R22-3-20210206","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity","volume":"89","author":"Ibanez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-3-20210206","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0188-4409(01)00325-3","article-title":"Mechanisms of hypothalamic\u2013pituitary\u2013gonadal disruption in polycystic ovarian syndrome","volume":"32","author":"Barontini","year":"2001","journal-title":"Arch Med Res"},{"key":"R24-3-20210206","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"R25-3-20210206","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpeds.2003.08.015","article-title":"Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome","volume":"144","author":"Ibanez","year":"2004","journal-title":"J Pediatr"},{"key":"R26-3-20210206","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jc.2003-031096","article-title":"Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease","volume":"89","author":"Boulman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-3-20210206","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.beem.2006.02.002","article-title":"Treatment of PCOS in adolescence","volume":"20","author":"Warren-Ulanch","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R28-3-20210206","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(97)06062-5","article-title":"Fetal growth, length of gestation, and polycystic ovaries in adult life","volume":"350","author":"Cresswell","year":"1997","journal-title":"Lancet"},{"key":"R29-3-20210206","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/humrep\/deg409","article-title":"Birth weight and age at menarche in patients with polycystic ovary syndrome or diminished ovarian reserve, in a retrospective cohort","volume":"18","author":"Sadrzadeh","year":"2003","journal-title":"Hum Reprod"},{"key":"R30-3-20210206","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","article-title":"Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth","volume":"83","author":"Ibanez","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-3-20210206","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1210\/jcem.84.12.6341","article-title":"Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age","volume":"84","author":"Ibanez","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-3-20210206","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/jcem.87.3.8305","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome","volume":"87","author":"Palmert","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-3-20210206","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2165\/00148581-200608050-00004","article-title":"Polycystic ovary syndrome in adolescents: current and future treatment options","volume":"8","author":"Mastorakos","year":"2006","journal-title":"Paediatr Drugs"},{"key":"R34-3-20210206","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/GRF.0b013e31802f5197","article-title":"Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician","volume":"50","author":"Lorenz","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"R35-3-20210206","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"R36-3-20210206","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/GRF.0b013e31802f35a0","article-title":"Pharmacologic therapy of polycystic ovary syndrome","volume":"50","author":"Dronavalli","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"R37-3-20210206","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0031-3955(05)70135-8","article-title":"Menstrual disorders in adolescents: excess androgens and the polycystic ovary syndrome","volume":"46","author":"Gordon","year":"1999","journal-title":"Pediatr Clin North Am"},{"issue":"1","key":"R38-3-20210206","first-page":"CD005552","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R40-3-20210206","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1542\/peds.114.1.141","article-title":"Evaluation of a type 2 diabetes screening protocol in an urban pediatric clinic","volume":"114","author":"Drobac","year":"2004","journal-title":"Pediatrics"},{"key":"R41-3-20210206","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.fertnstert.2005.08.045","article-title":"Role of diet in the treatment of polycystic ovary syndrome","volume":"85","author":"Douglas","year":"2006","journal-title":"Fertil Steril"},{"key":"R42-3-20210206","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00024677-200605030-00005","article-title":"Thiazolidinediones for the therapeutic management of polycystic ovary syndrome: impact on metabolic and reproductive abnormalities","volume":"5","author":"Elkind-Hirsch","year":"2006","journal-title":"Treat Endocrinol"},{"key":"R43-3-20210206","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"R44-3-20210206","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R45-3-20210206","first-page":"2057","article-title":"Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women","volume":"80","author":"Crave","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-3-20210206","first-page":"524","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-3-20210206","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-3-20210206","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jcem.86.8.7756","article-title":"Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism","volume":"86","author":"Ibanez","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R49-3-20210206","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1515\/JPEM.2005.18.8.761","article-title":"Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome","volume":"18","author":"Allen","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R50-3-20210206","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpedi.160.3.241","article-title":"Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome","volume":"160","author":"Bridger","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R51-3-20210206","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/humrep\/del185","article-title":"Metformin treatment is effective in obese teenage girls with PCOS","volume":"21","author":"De Leo","year":"2006","journal-title":"Hum Reprod"},{"key":"R52-3-20210206","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.beem.2006.02.003","article-title":"Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers","volume":"20","author":"Sharma","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R53-3-20210206","first-page":"1012","article-title":"Use of insulin sensitizers in polycystic ovarian syndrome","volume":"6","author":"Baillargeon","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"key":"R54-3-20210206","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ecl.2005.04.005","article-title":"Polycystic ovary syndrome in adolescence.","volume":"34","author":"Buggs","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"R55-3-20210206","first-page":"CD000194","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne.","author":"Farquhar","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R56-3-20210206","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03345529","article-title":"Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile","volume":"28","author":"Zulian","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"R57-3-20210206","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.beem.2006.03.003","article-title":"Treatment of hirsutism and acne in hyperandrogenism","volume":"20","author":"Moghetti","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R59-3-20210206","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2006-1988","article-title":"Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial","volume":"92","author":"Banaszewska","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0b013e328236743f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:36:36Z","timestamp":1620963396000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-200708000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e328236743f","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}